ArticleNature plants2026
Structural insights into the molecular mechanisms of OsFBN5-induced OsSPS3 catalysis.
Article in Nature plants, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Solanesyl diphosphate synthase (SPS) is crucial for photosynthesis, as it supplies prenyl precursors for the biosynthesis of the photosynthetic electron carrier, plastoquinone-9 (PQ-9). Fibrillin 5 (FBN5) stimulates SPS catalytic activity through direct binding, which is essential for normal plant growth. However, the molecular mechanism of FBN5-mediated SPS catalytic regulation remains unclear. In Oryza sativa (rice), OsSPS3 is an important plastid-localized SPS isoform involved in PQ-9 formation. The Osfbn5 mutant plants display photodamage with exacerbated PQ-9 deficiency when exposed to high light. Here rice serves as a model organism to study SPS and FBN5. We report the crystal structures of the apo and inhibitor-bound forms of OsSPS3, revealing the alternating catalytic mechanism of the asymmetric OsSPS3 dimer. In addition, we report the cryo-electron microscopy structures of the apo and ligand-bound forms of the OsSPS3-FBN5 complex, showing that OsFBN5 binding triggers an open-to-closed conformational transition of a lid-like capping loop within the inactive monomer of OsSPS3, allowing both monomers of dimeric OsSPS3 to be catalytically active. A comparison of the enzymatic activities of the wild-type OsSPS3 homodimer and a recombinant OsSPS3 heterodimer containing one inactive mutant subunit revealed that OsFBN5 enhances the activity of OsSPS3 by inducing a synchronous catalytic mechanism. This work reveals the dynamic catalytic mechanism of OsSPS3 and provides a structural basis for understanding its function and the FBN5-mediated regulation of the PQ-9 biosynthesis pathway.
Indexed as
Identifiers
41491069What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.